Cargando…

Combination of bortezomib-based chemotherapy and extracorporeal free light chain removal for treating cast nephropathy in multiple myeloma

Besides amyloidosis and light chain deposition disease, the most common histological type of renal lesion is cast nephropathy in 30% of patients with multiple myeloma [2]. In contrast to amyloidosis, cast nephropathy is believed to be potentially reversible when circulating light chains are rapidly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bachmann, Ulrike, Schindler, Ralf, Storr, Markus, Kahl, Andreas, Joerres, Achim, Sturm, Isrid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2008
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477910/ https://www.ncbi.nlm.nih.gov/pubmed/28657037 http://dx.doi.org/10.1093/ndtplus/sfm053

Ejemplares similares

Crystalline light chain cast nephropathy in multiple myeloma
por: Lin, Zi-Shan, et al.
Publicado: (2021)

Multiple myeloma with acute light chain cast nephropathy
por: Leung, Nelson, et al.
Publicado: (2023)

Multiple Myeloma–Associated Ig Light Chain Crystalline Cast Nephropathy
por: Matsumura, Hirotoshi, et al.
Publicado: (2020)

Light chain proximal tubulopathy with cast nephropathy in a case of multiple myeloma
por: Gowda, K. K., et al.
Publicado: (2015)

Light Chain Cast Nephropathy in Multiple Myeloma: Prevalence, Impact and Management Challenges
por: Menè, Paolo, et al.
Publicado: (2022)

Resolution of cast nephropathy following free light chain removal by haemodialysis in a patient with multiple myeloma: a case report
por: Basnayake, Kolitha, et al.
Publicado: (2008)

UMOD genetic variations and myeloma cast nephropathy
por: Belliere, Julie, et al.
Publicado: (2019)

Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study
por: Yadav, Punit, et al.
Publicado: (2020)

Multiple Myeloma: Cast Nephropathy, VTE, and Neurologic Complications
por: Sullivan, Ellen, et al.
Publicado: (2013)

Recent Advances in the Pathogenesis and Management of Cast Nephropathy (Myeloma Kidney)
por: Stringer, Stephanie, et al.
Publicado: (2011)

Cisplatin-Induced Nephrotoxicity and HIV Associated Nephropathy: Mimickers of Myeloma-Like Cast Nephropathy
por: Khurram, Muhammad Siddique, et al.
Publicado: (2017)

Myeloma cast nephropathy with diffuse amyloid casts without systemic amyloidosis: two cases report
por: Yong, Zi-hao, et al.
Publicado: (2021)

Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy
por: Hutchison, Colin A, et al.
Publicado: (2012)

Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma
por: Wu, Chung-Kuan, et al.
Publicado: (2017)

Two kinds of rare light chain cast nephropathy caused by multiple myeloma: case reports and literature review
por: Sun, Li-Jun, et al.
Publicado: (2021)

Lambda Light Chain Crystalline Cast Nephropathy and Proximal Tubulopathy
por: Gallan, Alexander J., et al.
Publicado: (2016)

Light chain cast nephropathy caused by plasmablastic lymphoma of the bladder
por: Jafarizade, Mehrian, et al.
Publicado: (2021)

Myeloma Cast Nephropathy an Unusual Association with HIV Infection Presenting with Renal Dysfunction
por: Subramanian, Kalaivani S., et al.
Publicado: (2022)

Bortezomib in the management of multiple myeloma
por: Laubach, Jacob P, et al.
Publicado: (2009)

Waldenström Macroglobulinemia: Unusual Presentation With Cast Nephropathy/Light Chain Tubulopathy
por: Ashraf, Muddasir, et al.
Publicado: (2019)

Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy
por: Rousseau-Gagnon, Mathieu, et al.
Publicado: (2015)

An Unusual Case of Multiple Myeloma with Light-Chain Cast Nephropathy Secondary to a Very Large Plasmacytoma without Bone Marrow Involvement
por: Komisarof, Justin, et al.
Publicado: (2022)

European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): A randomised control trial
por: Hutchison, Colin A, et al.
Publicado: (2008)

Hemoglobin Cast Nephropathy
por: Mahmud, Saqib, et al.
Publicado: (2020)

Case Report on Renal Failure Reversal in Lambda Chain Multiple Myeloma with Bortezomib and Dexamethasone
por: Patibandla, Bhanu K., et al.
Publicado: (2014)

Bortezomib (Velcade™) in the Treatment of Multiple Myeloma
por: Field-Smith, Antonia, et al.
Publicado: (2006)

Acute kidney injury on chronic kidney disease: from congestive heart failure to light chain deposition disease and cast nephropathy in multiple myeloma
por: Shaikh, Sana, et al.
Publicado: (2019)

Early Light Chains Removal and Albumin Levels with a Double Filter-Based Extracorporeal Treatment for Acute Myeloma Kidney
por: Donati, Gabriele, et al.
Publicado: (2022)

Bortezomib for Reduction of Proteinuria in IgA Nephropathy
por: Hartono, Choli, et al.
Publicado: (2018)

Treatment of Coexisting Chronic Neutrophilic Leukemia and Light Chain Multiple Myeloma with Hydroxyurea, Bortezomib, and Dexamethasone
por: Taiwo, Evelyn, et al.
Publicado: (2014)

Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis
por: Sidana, Surbhi, et al.
Publicado: (2017)

Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
por: Kraus, M, et al.
Publicado: (2013)

Clinical outcomes of bortezomib-based therapy in myeloma
por: Djebbari, Faouzi, et al.
Publicado: (2018)

Bortezomib Treatment Modulates Autophagy in Multiple Myeloma
por: Di Lernia, Giuseppe, et al.
Publicado: (2020)

Entinostat-Bortezomib Hybrids against Multiple Myeloma
por: Ferro, Angelica, et al.
Publicado: (2023)

Coexistent Amyloid Fibrils in a Patient with Combined Light Chain Deposition Disease and Light Chain Cast Nephropathy
por: Anandh, Urmila, et al.
Publicado: (2019)

Myeloma Cast Nephropathy and COVID-19: A Case Report of Multiple Myeloma Presenting as Acute Kidney Injury in the Setting of COVID-19
por: Memon, Waqas, et al.
Publicado: (2021)

Complete remission of lambda light chain myeloma presenting with acute renal failure following treatment with bortezomib and steroids
por: Pavan, M., et al.
Publicado: (2010)

Bortezomib: the evidence of its clinical impact in multiple myeloma
por: Lancaster, Simon
Publicado: (2006)

Subcutaneous bortezomib for multiple myeloma treatment: patients’ benefits
por: Petrucci, Maria Teresa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lt0k9pls1m7ndc34enbkfs3ccn